A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction by Ejemel, M, Li, Q, Hou, S, Schiller, ZA, Tree, JA, Wallace, A, Amcheslavsky, A, Kurt Yilmaz, N, Buttigieg, KR, Elmore, MJ, Godwin, K, Coombes, N, Toomey, JR, Schneider, R, Ramchetty, AS, Close, BJ, Chen, D-Y, Conway, HL, Saeed, M, Ganesa, C, Carroll, MW, Cavacini, LA, Klempner, MS, Schiffer, CA, Wang, Y

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 by Huo, J, Le Bas, A, Ruza, RR, Duyvesten, HME, Mikolajek, H, Malinauskas, T, Tan, TK, Rijal, P, Dumoux, M, Ward, PN, Ren, J, Zhou, D, Harrison, PJ, Weckener, M, Clare, DK, Vogirala, VK, Radecke, J, Moynié, L, Zhao, Y, Gilbert-Jaramillo, J, Knight, ML, Tree, JA, Buttigieg, KR, Coombes, N, Elmore, MJ, Carroll, MW, Carrique, L, Shah, PNM, James, W, Townsend, AR, Stuart, DI, Owens, RJ, Naismith, JH

A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 by Huo, J, Mikolajek, H, Le Bas, A, Clark, JJ, Sharma, P, Kipar, A, Dormon, J, Norman, C, Weckener, M, Clare, DK, Harrison, PJ, Tree, JA, Buttigieg, KR, Salguero, FJ, Watson, R, Knott, D, Carnell, O, Ngabo, D, Elmore, MJ, Fotheringham, S, Harding, A, Moynié, L, Ward, PN, Dumoux, M, Prince, T, Hall, Y, Hiscox, JA, Owen, A, James, W, Carroll, MW, Stewart, JP, Naismith, JH, Owens, RJ